Anti-CD19 CAR T cell therapy for lymphoma — off to the races!

Overview of attention for article published in Nature Reviews Clinical Oncology, February 2019

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 39,922 followers.

Anti-CD19 CAR T cell therapy for lymphoma - off to the races! - PubMed - NCBI https://t.co/R5MFxYa7X0

Live today: David Maloney discussed the ZUMA-1 and JULIET trials in a News and Views https://t.co/CU2xiTxgtG https://t.co/pHec08y8Sb

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.